封面
市場調查報告書
商品編碼
1697358

深層腦部刺激器市場:2025-2030 年預測

Deep Brain Stimulation Devices Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

深部腦部刺激 (DBS) 設備市場預計將從 2025 年的 1,979,749,000 美元成長到 2030 年的 3,237,249,000 美元,預測期內的複合年成長率為 10.33%。

由於神經系統疾病盛行率不斷上升、技術進步以及人們對 DBS 療法的認知不斷提高,全球深部腦部刺激設備市場預計將以顯著的速度成長。

市場趨勢

  • 神經系統疾病盛行率不斷上升:帕金森氏症、自發性震顫和肌張力不全症等神經系統疾病盛行率不斷上升是市場成長的主要驅動力。例如,帕金森基金會估計,全球有超過 1,000 萬人患有帕金森氏症。中風也是一個主要因素,預計全球整體四分之一的 25 歲及以上人群在其一生中會經歷中風。
  • 技術進步:持續的技術進步,包括改進的導線設計、植入式脈衝產生器、遠端監控能力和增強的運算能力,正在提高 DBS 治療的有效性和安全性。最近的創新包括具有遠端編程功能的緊湊型可充電 DBS 系統。
  • 提高意識和接受度:在政府措施和政策的推動下,全球對 DBS 療法的認知和接受度不斷提高,這有助於市場擴張。
  • 微創手術:對微創手術的不斷成長的需求也推動了市場的成長。 Picostim DBS 系統是一種新型微型 DBS 設備,旨在減少與傳統 DBS 手術相關的併發症和成本。

地理視角

  • 北美:由於技術進步不斷加快、研發生態系統強大以及美國主要市場參與者的穩固地位,北美預計將主導 DBS 設備市場。
  • 歐洲:由於醫療保健領域的進步以及對微創醫療干預的關注,歐洲預計將實現顯著成長。
  • 亞太地區:受可支配收入增加、人們對神經系統疾病的認知不斷提高以及政府對醫療保健計劃的支持推動,亞太地區預計將出現最高成長。
  • 南美洲、中東和非洲:由於醫療保健領域的技術進步率較低,預計南美洲、中東和非洲的成長速度將放緩。

為什麼要購買這份報告?

  • 深刻分析:獲得涵蓋主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局:了解全球主要企業採取的策略策略,並了解正確策略帶來的潛在市場滲透。
  • 市場趨勢和促進因素:探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
  • 可行的建議:利用洞察力做出策略決策,在動態環境中開闢新的業務流和收益。
  • 適用範圍廣:對於新興企業、科學研究機構、顧問公司、中小企業、大型企業都有利且划算。

它有什麼用途?

產業和市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的歷史資料與預測
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 細分和區域分析,包括收益成長和預測國家
  • 公司概況(包括主要趨勢)

深層腦部刺激器市場分析為以下幾個部分:

按應用

  • 帕金森氏症
  • 癲癇
  • 自發性震顫
  • 肌張力不全症
  • 其他(強迫性精神官能症、妥瑞症)

依產品類型

  • 單通道深層腦部刺激器
  • 雙通道深層腦部刺激器

按最終用戶

  • 醫院
  • 門診手術中心
  • 神經科診所

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 南美洲
  • 韓國
  • 澳洲
  • 新加坡
  • 印尼
  • 其他
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國等

目錄

第1章執行摘要

  • 市場概覽
  • 主要趨勢和見解
  • 市場規模及預測

第 2 章 簡介

  • 定義和範圍
  • 都市化加速
  • 永續性的重要性

第3章 市場動態

  • 市場成長動力
  • 挑戰與障礙
  • 新興市場機會
  • 監管和環境因素

第4章 細分分析

  • 按應用
    • 帕金森氏症
    • 癲癇
    • 自發性震顫
    • 肌張力不全症
    • 其他
  • 依產品類型
    • 單通道深層腦部刺激器
    • 雙通道深層腦部刺激器
  • 按最終用戶
    • 醫院
    • 門診手術中心
    • 神經科診所
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東和非洲

第5章 競爭格局

  • 主要市場參與者
  • 公司簡介及策略
  • 市場佔有率分析

第6章 市場趨勢與創新

  • 神經系統疾病發生率增加。
  • 技術進步仍在持續。
  • 醫療保健技術的創新和投資。
  • 提高全球對深部腦部刺激的接受度和認知。

第7章 市場展望與預測

  • 市場規模和成長預測
  • 區域市場展望

第8章法規結構

  • 智慧財產
  • 資料隱私和安全

第9章案例研究與產業應用

  • 帕金森氏症和癲癇治療設備
  • 單通道和雙通道深層腦部刺激器
  • 神經學應用的儀器和設備

第10章結論與建議

  • 關鍵要點
  • 向相關人員提出的策略建議

第11章 附錄

  • 調查方法
  • 資料來源與參考文獻
  • 詞彙表
簡介目錄
Product Code: KSI061616645

The Deep Brain Stimulation (DBS) Devices Market is set to witness robust growth at a CAGR of 10.33% during the forecast period to be worth US$3,237.249 million in 2030 from US$1,979.749 million in 2025.

The global deep brain stimulation (DBS) devices market is poised for substantial growth, driven by the increasing prevalence of neurological disorders, technological advancements, and growing awareness of DBS therapy.

Market Trends

  • Increasing Prevalence of Neurological Disorders: The rising incidence of neurological conditions such as Parkinson's disease, essential tremors, and dystonia is a primary driver of market growth. For instance, the Parkinson's Foundation estimates that over 10 million individuals worldwide suffer from Parkinson's disease. Stroke is another major factor; globally, one in every four people aged 25 or older is expected to experience a stroke in their lifetime.
  • Technological Advancements: Ongoing technological advancements, including improvements in lead design, implantable pulse generators, remote monitoring capabilities, and increased computing power, are enhancing the effectiveness and safety of DBS therapy. Recent innovations include smaller, rechargeable DBS systems with remote programming capabilities.
  • Growing Awareness and Acceptance: Increasing global awareness and acceptance of DBS therapy, facilitated by governmental initiatives and policies, are contributing to market expansion.
  • Minimally Invasive Procedures: Escalating demand for minimally invasive procedures is also propelling the market growth. A novel miniaturized DBS device, the Picostim DBS system, aims to mitigate complications and reduce costs associated with traditional DBS surgery.

Geographical Outlook

  • North America: North America is expected to dominate the DBS devices market due to increasing technological advancements, a strong research and development ecosystem, and the established presence of major market players in the U.S.
  • Europe: Europe is projected to experience significant growth due to advancements in its healthcare sector and a focus on minimally invasive medical interventions. Increasing government spending on mental health services is also a driving factor in the UK.
  • Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth, driven by increasing disposable incomes, growing awareness of neurological conditions, and government support for healthcare initiatives.
  • South America and MEA: South America and the Middle East & Africa are expected to experience slower growth due to a lower rate of technological advancements in their healthcare sectors.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Deep Brain Stimulation Devices Market is analyzed into the following segments:

By Application

  • Parkinson's Disease
  • Epilepsy
  • Essential Tremor
  • Dystonia
  • Others (OCD and Tourette syndrome)

By Product Type

  • Single-channel Deep Brain Stimulators
  • Dual-channel Deep Brain Stimulators

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Neurological Clinics

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Others
  • South America
  • Brazil
  • Argentina
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

  • 1.1. Market Overview
  • 1.2. Key Trends and Insights
  • 1.3. Market Size and Forecast

2. INTRODUCTION

  • 2.1. Definition and Scope
  • 2.2. Growing urbanization
  • 2.3. Importance of sustainability

3. MARKET DYNAMICS

  • 3.1. Drivers of Market Growth
  • 3.2. Challenges and Barriers
  • 3.3. Opportunities in Emerging Markets
  • 3.4. Regulatory and Environmental Factors

4. SEGMENTATION ANALYSIS

  • 4.1. By Application
    • 4.1.1. Parkinson's Disease
    • 4.1.2. Epilepsy
    • 4.1.3. Essential Tremor
    • 4.1.4. Dystonia
    • 4.1.5. Others
  • 4.2. By Product Type
    • 4.2.1. Single-channel Deep Brain Stimulators
    • 4.2.2. Dual-channel Deep Brain Stimulators
  • 4.3. By End-User
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgical Centers
    • 4.3.3. Neurological Clinics
  • 4.4. By Geography
    • 4.4.1. North America
      • 4.4.1.1. United States
      • 4.4.1.2. Canada
      • 4.4.1.3. Mexico
    • 4.4.2. Europe
      • 4.4.2.1. United Kingdom
      • 4.4.2.2. Germany
      • 4.4.2.3. France
      • 4.4.2.4. Spain
      • 4.4.2.5. Others
    • 4.4.3. Asia Pacific
      • 4.4.3.1. China
      • 4.4.3.2. Japan
      • 4.4.3.3. India
      • 4.4.3.4. South Korea
      • 4.4.3.5. Australia
      • 4.4.3.6. Singapore
      • 4.4.3.7. Indonesia
      • 4.4.3.8. Others
    • 4.4.4. South America
      • 4.4.4.1. Brazil
      • 4.4.4.2. Argentina
      • 4.4.4.3. Others
    • 4.4.5. Middle East & Africa
      • 4.4.5.1. Saudi Arabia
      • 4.4.5.2. UAE
      • 4.4.5.3. Others

5. COMPETITIVE LANDSCAPE

  • 5.1. Key Market Players
  • 5.2. Company Profiles and Strategies
  • 5.3. Market Share Analysis

6. MARKET TRENDS AND INNOVATIONS

  • 6.1. Growing prevalence of neurological disorders.
  • 6.2. Increasing technological advancement.
  • 6.3. Innovations and investments in healthcare technology.
  • 6.4. Growing global acceptance and awareness of deep brain stimulation.

7. MARKET OUTLOOK AND FORECAST

  • 7.1. Market Size and Growth Projections
  • 7.2. Regional Market Outlook

8. REGULATORY FRAMEWORK

  • 8.1. Intellectual Property Rights
  • 8.2. Data Privacy and Security

9. CASE STUDIES AND INDUSTRY APPLICATIONS

  • 9.1. Parkinson's and Epilepsy devices
  • 9.2. Single and Dual-channel Deep Brain Stimulators
  • 9.3. Equipment and Devices for neurological application

10. CONCLUSION AND RECOMMENDATIONS

  • 10.1. Key Takeaways
  • 10.2. Strategic Recommendations for Stakeholders

11. APPENDICES

  • 11.1. Research Methodology
  • 11.2. Data Sources and References
  • 11.3. Glossary of Terms